Companies Dominating the DiGeorge Syndrome Drug Landscape
- F. Hoffmann-La Roche Ltd
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer Inc.
- Cerecor, Inc.
- Bausch Health Companies Inc.
- Natera, Inc
- Boehringer Ingelheim International GmbH, AbbVie Inc.
- Amgen Inc.
- Novartis AG
- Progenity, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
DiGeorge Syndrome Drug Market size is set to register remarkable growth rate during the forecast period i.e., between 2025-2037.
The market growth is driven by growing patient pool of the disease and the need for treatment for the wide range of symptoms caused by this genetic disorder.
North America industry is set to account for largest revenue share by 2037, on the back of rising prevalence of the disorder.
The major players in the market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Cerecor, Inc., Bausch Health Companies Inc., Natera, Inc, Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc., Novartis AG and Progenity, Inc., among others.
